CATB-101

N/A

Report date: 2026/04/16 20:00:17

Base Information

Drug NameCATB-101
Drug Alias NameCATB-101CATB101
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Trop-2Tubulin inhibitorsDNA topoisomerase I inhibitors
TargetsTumor-associated calcium signal transducer 2TubulinDNA topoisomerase I
Therapy Area/IndicationsSolid tumoursTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCatena Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesCatena Biosciences Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A